Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FU194
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,334
Award facts
- Contract value 100% obligated
- $24,334.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,334.11 delivery order to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 mL pens on November 26, 2025, with an ultimate completion date of November 28, 2025. This firm fixed-price delivery order, which does not utilize a set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency and military healthcare systems. The company's delivery order portfolio demonstrates extensive experience fulfilling competitive federal contracts for specialized medications, including diabetes treatments, neurological pharmaceuticals, and other therapeutic products across multiple disease states. This delivery order for Wegovy, a GLP-1 receptor agonist medication, reflects the company's role in supplying pharmaceutical commodities essential to military and federal employee healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FU194?
SPE2DR26FU194 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FU194 worth?
The government has obligated $24,334 on SPE2DR26FU194.
Is contract SPE2DR26FU194 an order under another contract?
Yes. SPE2DR26FU194 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU194 competed?
The extent of competition for SPE2DR26FU194 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award